Summary

The global Pig Disease Medication market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Compound Sulfamethoxine Sodium Injection is a western medicine preparation, mainly used for streptococcosis, toxoplasmosis and other diseases in pigs.
In 2025, the North America Pig Disease Medication market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
Major global manufacturers of Pig Disease Medication include MUGREEN, Tongren Pharmaceutical, HUADI Group, Kunyuan Biology, Hong Bao, Xinheng Pharmaceutical, Keda Animal Pharmaceutical, Yuan Ye Biology, Yi Ge Feng, Jiuding Animal Pharmaceutical, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Pig Disease Medication market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
MUGREEN
Tongren Pharmaceutical
HUADI Group
Kunyuan Biology
Hong Bao
Xinheng Pharmaceutical
Keda Animal Pharmaceutical
Yuan Ye Biology
Yi Ge Feng
Jiuding Animal Pharmaceutical
DEPOND
Bullvet
Tong Yu Group
Huabang Biotechnology
Chengkang Pharmaceutical
FANGTONG ANIMAL PHARMACEUTICAL
Jin He Biotechnology
Segment by Type
Diarrhea
Virus
Others
Segment by Application
Farm
Household
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Pig Disease Medication sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Pig Disease Medication manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Pig Disease Medication product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Pig Disease Medication value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Pig Disease Medication Product Scope
1.2 Pig Disease Medication by Type
1.2.1 Global Pig Disease Medication Sales by Type (2021, 2025 & 2032)
1.2.2 Diarrhea
1.2.3 Virus
1.2.4 Others
1.3 Pig Disease Medication by Application
1.3.1 Global Pig Disease Medication Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Farm
1.3.3 Household
1.4 Global Pig Disease Medication Market Estimates and Forecasts (2021-2032)
1.4.1 Global Pig Disease Medication Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Pig Disease Medication Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Pig Disease Medication Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Pig Disease Medication Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Pig Disease Medication Historical Market Scenario by Region (2021-2026)
2.2.1 Global Pig Disease Medication Sales Market Share by Region (2021-2026)
2.2.2 Global Pig Disease Medication Revenue Market Share by Region (2021-2026)
2.3 Global Pig Disease Medication Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Pig Disease Medication Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Pig Disease Medication Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Pig Disease Medication Market Size and Prospects (2021-2032)
2.4.2 Europe Pig Disease Medication Market Size and Prospects (2021-2032)
2.4.3 China Pig Disease Medication Market Size and Prospects (2021-2032)
2.4.4 Japan Pig Disease Medication Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Pig Disease Medication Historical Market Review by Type (2021-2026)
3.1.1 Global Pig Disease Medication Sales by Type (2021-2026)
3.1.2 Global Pig Disease Medication Revenue by Type (2021-2026)
3.1.3 Global Pig Disease Medication Average Price by Type (2021-2026)
3.2 Global Pig Disease Medication Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Pig Disease Medication Sales Forecast by Type (2027-2032)
3.2.2 Global Pig Disease Medication Revenue Forecast by Type (2027-2032)
3.2.3 Global Pig Disease Medication Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Pig Disease Medication
4 Global Market Size by Application
4.1 Global Pig Disease Medication Historical Market Review by Application (2021-2026)
4.1.1 Global Pig Disease Medication Sales by Application (2021-2026)
4.1.2 Global Pig Disease Medication Revenue by Application (2021-2026)
4.1.3 Global Pig Disease Medication Average Price by Application (2021-2026)
4.2 Global Pig Disease Medication Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Pig Disease Medication Sales Forecast by Application (2027-2032)
4.2.2 Global Pig Disease Medication Revenue Forecast by Application (2027-2032)
4.2.3 Global Pig Disease Medication Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Pig Disease Medication Applications
5 Competition Landscape by Players
5.1 Global Pig Disease Medication Sales by Player (2021-2026)
5.2 Global Top Pig Disease Medication Players by Revenue (2021-2026)
5.3 Global Pig Disease Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Pig Disease Medication revenue as of 2025
5.4 Global Pig Disease Medication Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Pig Disease Medication, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Pig Disease Medication, Product Type & Application
5.7 Global Key Manufacturers of Pig Disease Medication, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Pig Disease Medication Sales by Company
6.1.1.1 North America Pig Disease Medication Sales by Company (2021-2026)
6.1.1.2 North America Pig Disease Medication Revenue by Company (2021-2026)
6.1.2 North America Pig Disease Medication Sales Breakdown by Type (2021-2026)
6.1.3 North America Pig Disease Medication Sales Breakdown by Application (2021-2026)
6.1.4 North America Pig Disease Medication Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Pig Disease Medication Sales by Company
6.2.1.1 Europe Pig Disease Medication Sales by Company (2021-2026)
6.2.1.2 Europe Pig Disease Medication Revenue by Company (2021-2026)
6.2.2 Europe Pig Disease Medication Sales Breakdown by Type (2021-2026)
6.2.3 Europe Pig Disease Medication Sales Breakdown by Application (2021-2026)
6.2.4 Europe Pig Disease Medication Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Pig Disease Medication Sales by Company
6.3.1.1 China Pig Disease Medication Sales by Company (2021-2026)
6.3.1.2 China Pig Disease Medication Revenue by Company (2021-2026)
6.3.2 China Pig Disease Medication Sales Breakdown by Type (2021-2026)
6.3.3 China Pig Disease Medication Sales Breakdown by Application (2021-2026)
6.3.4 China Pig Disease Medication Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Pig Disease Medication Sales by Company
6.4.1.1 Japan Pig Disease Medication Sales by Company (2021-2026)
6.4.1.2 Japan Pig Disease Medication Revenue by Company (2021-2026)
6.4.2 Japan Pig Disease Medication Sales Breakdown by Type (2021-2026)
6.4.3 Japan Pig Disease Medication Sales Breakdown by Application (2021-2026)
6.4.4 Japan Pig Disease Medication Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 MUGREEN
7.1.1 MUGREEN Company Information
7.1.2 MUGREEN Business Overview
7.1.3 MUGREEN Pig Disease Medication Sales, Revenue and Gross Margin (2021-2026)
7.1.4 MUGREEN Pig Disease Medication Products Offered
7.1.5 MUGREEN Recent Development
7.2 Tongren Pharmaceutical
7.2.1 Tongren Pharmaceutical Company Information
7.2.2 Tongren Pharmaceutical Business Overview
7.2.3 Tongren Pharmaceutical Pig Disease Medication Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Tongren Pharmaceutical Pig Disease Medication Products Offered
7.2.5 Tongren Pharmaceutical Recent Development
7.3 HUADI Group
7.3.1 HUADI Group Company Information
7.3.2 HUADI Group Business Overview
7.3.3 HUADI Group Pig Disease Medication Sales, Revenue and Gross Margin (2021-2026)
7.3.4 HUADI Group Pig Disease Medication Products Offered
7.3.5 HUADI Group Recent Development
7.4 Kunyuan Biology
7.4.1 Kunyuan Biology Company Information
7.4.2 Kunyuan Biology Business Overview
7.4.3 Kunyuan Biology Pig Disease Medication Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Kunyuan Biology Pig Disease Medication Products Offered
7.4.5 Kunyuan Biology Recent Development
7.5 Hong Bao
7.5.1 Hong Bao Company Information
7.5.2 Hong Bao Business Overview
7.5.3 Hong Bao Pig Disease Medication Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Hong Bao Pig Disease Medication Products Offered
7.5.5 Hong Bao Recent Development
7.6 Xinheng Pharmaceutical
7.6.1 Xinheng Pharmaceutical Company Information
7.6.2 Xinheng Pharmaceutical Business Overview
7.6.3 Xinheng Pharmaceutical Pig Disease Medication Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Xinheng Pharmaceutical Pig Disease Medication Products Offered
7.6.5 Xinheng Pharmaceutical Recent Development
7.7 Keda Animal Pharmaceutical
7.7.1 Keda Animal Pharmaceutical Company Information
7.7.2 Keda Animal Pharmaceutical Business Overview
7.7.3 Keda Animal Pharmaceutical Pig Disease Medication Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Keda Animal Pharmaceutical Pig Disease Medication Products Offered
7.7.5 Keda Animal Pharmaceutical Recent Development
7.8 Yuan Ye Biology
7.8.1 Yuan Ye Biology Company Information
7.8.2 Yuan Ye Biology Business Overview
7.8.3 Yuan Ye Biology Pig Disease Medication Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Yuan Ye Biology Pig Disease Medication Products Offered
7.8.5 Yuan Ye Biology Recent Development
7.9 Yi Ge Feng
7.9.1 Yi Ge Feng Company Information
7.9.2 Yi Ge Feng Business Overview
7.9.3 Yi Ge Feng Pig Disease Medication Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Yi Ge Feng Pig Disease Medication Products Offered
7.9.5 Yi Ge Feng Recent Development
7.10 Jiuding Animal Pharmaceutical
7.10.1 Jiuding Animal Pharmaceutical Company Information
7.10.2 Jiuding Animal Pharmaceutical Business Overview
7.10.3 Jiuding Animal Pharmaceutical Pig Disease Medication Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Jiuding Animal Pharmaceutical Pig Disease Medication Products Offered
7.10.5 Jiuding Animal Pharmaceutical Recent Development
7.11 DEPOND
7.11.1 DEPOND Company Information
7.11.2 DEPOND Business Overview
7.11.3 DEPOND Pig Disease Medication Sales, Revenue and Gross Margin (2021-2026)
7.11.4 DEPOND Pig Disease Medication Products Offered
7.11.5 DEPOND Recent Development
7.12 Bullvet
7.12.1 Bullvet Company Information
7.12.2 Bullvet Business Overview
7.12.3 Bullvet Pig Disease Medication Sales, Revenue and Gross Margin (2021-2026)
7.12.4 Bullvet Pig Disease Medication Products Offered
7.12.5 Bullvet Recent Development
7.13 Tong Yu Group
7.13.1 Tong Yu Group Company Information
7.13.2 Tong Yu Group Business Overview
7.13.3 Tong Yu Group Pig Disease Medication Sales, Revenue and Gross Margin (2021-2026)
7.13.4 Tong Yu Group Pig Disease Medication Products Offered
7.13.5 Tong Yu Group Recent Development
7.14 Huabang Biotechnology
7.14.1 Huabang Biotechnology Company Information
7.14.2 Huabang Biotechnology Business Overview
7.14.3 Huabang Biotechnology Pig Disease Medication Sales, Revenue and Gross Margin (2021-2026)
7.14.4 Huabang Biotechnology Pig Disease Medication Products Offered
7.14.5 Huabang Biotechnology Recent Development
7.15 Chengkang Pharmaceutical
7.15.1 Chengkang Pharmaceutical Company Information
7.15.2 Chengkang Pharmaceutical Business Overview
7.15.3 Chengkang Pharmaceutical Pig Disease Medication Sales, Revenue and Gross Margin (2021-2026)
7.15.4 Chengkang Pharmaceutical Pig Disease Medication Products Offered
7.15.5 Chengkang Pharmaceutical Recent Development
7.16 FANGTONG ANIMAL PHARMACEUTICAL
7.16.1 FANGTONG ANIMAL PHARMACEUTICAL Company Information
7.16.2 FANGTONG ANIMAL PHARMACEUTICAL Business Overview
7.16.3 FANGTONG ANIMAL PHARMACEUTICAL Pig Disease Medication Sales, Revenue and Gross Margin (2021-2026)
7.16.4 FANGTONG ANIMAL PHARMACEUTICAL Pig Disease Medication Products Offered
7.16.5 FANGTONG ANIMAL PHARMACEUTICAL Recent Development
7.17 Jin He Biotechnology
7.17.1 Jin He Biotechnology Company Information
7.17.2 Jin He Biotechnology Business Overview
7.17.3 Jin He Biotechnology Pig Disease Medication Sales, Revenue and Gross Margin (2021-2026)
7.17.4 Jin He Biotechnology Pig Disease Medication Products Offered
7.17.5 Jin He Biotechnology Recent Development
8 Pig Disease Medication Manufacturing Cost Analysis
8.1 Pig Disease Medication Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Pig Disease Medication
8.4 Pig Disease Medication Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Pig Disease Medication Distributors List
9.3 Pig Disease Medication Customers
10 Pig Disease Medication Market Dynamics
10.1 Pig Disease Medication Industry Trends
10.2 Pig Disease Medication Market Drivers
10.3 Pig Disease Medication Market Challenges
10.4 Pig Disease Medication Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Pig Disease Medication Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)
Table 2. Global Pig Disease Medication Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)
Table 3. Global Market Pig Disease Medication Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Table 4. Global Pig Disease Medication Sales (K Units) by Region (2021-2026)
Table 5. Global Pig Disease Medication Sales Market Share by Region (2021-2026)
Table 6. Global Pig Disease Medication Revenue (US$ Million) Market Share by Region (2021-2026)
Table 7. Global Pig Disease Medication Revenue Share by Region (2021-2026)
Table 8. Global Pig Disease Medication Sales (K Units) Forecast by Region (2027-2032)
Table 9. Global Pig Disease Medication Sales Market Share Forecast by Region (2027-2032)
Table 10. Global Pig Disease Medication Revenue (US$ Million) Forecast by Region (2027-2032)
Table 11. Global Pig Disease Medication Revenue Share Forecast by Region (2027-2032)
Table 12. Global Pig Disease Medication Sales by Type (K Units) & (2021-2026)
Table 13. Global Pig Disease Medication Sales Share by Type (2021-2026)
Table 14. Global Pig Disease Medication Revenue by Type (US$ Million) & (2021-2026)
Table 15. Global Pig Disease Medication Average Price by Type (US$/Unit) & (2021-2026)
Table 16. Global Pig Disease Medication Sales by Type (K Units) & (2027-2032)
Table 17. Global Pig Disease Medication Revenue by Type (US$ Million) & (2027-2032)
Table 18. Global Pig Disease Medication Average Price by Type (US$/Unit) & (2027-2032)
Table 19. Representative Players of Each Type
Table 20. Global Pig Disease Medication Sales by Application (K Units) & (2021-2026)
Table 21. Global Pig Disease Medication Sales Share by Application (2021-2026)
Table 22. Global Pig Disease Medication Revenue by Application (US$ Million) & (2021-2026)
Table 23. Global Pig Disease Medication Average Price by Application (US$/Unit) & (2021-2026)
Table 24. Global Pig Disease Medication Sales by Application (K Units) & (2027-2032)
Table 25. Global Pig Disease Medication Revenue Market Share by Application (US$ Million) & (2027-2032)
Table 26. Global Pig Disease Medication Average Price by Application (US$/Unit) & (2027-2032)
Table 27. New Sources of Growth in Pig Disease Medication Applications
Table 28. Global Pig Disease Medication Sales by Company (K Units) & (2021-2026)
Table 29. Global Pig Disease Medication Sales Share by Company (2021-2026)
Table 30. Global Pig Disease Medication Revenue by Company (US$ Million) & (2021-2026)
Table 31. Global Pig Disease Medication Revenue Share by Company (2021-2026)
Table 32. Global Pig Disease Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pig Disease Medication as of 2025)
Table 33. Global Market Pig Disease Medication Average Price by Company (US$/Unit) & (2021-2026)
Table 34. Global Key Manufacturers of Pig Disease Medication, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Pig Disease Medication, Product Type & Application
Table 36. Global Key Manufacturers of Pig Disease Medication, Date of Entry into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Pig Disease Medication Sales by Company (2021-2026) & (K Units)
Table 39. North America Pig Disease Medication Sales Market Share by Company (2021-2026)
Table 40. North America Pig Disease Medication Revenue by Company (2021-2026) & (US$ Million)
Table 41. North America Pig Disease Medication Revenue Market Share by Company (2021-2026)
Table 42. North America Pig Disease Medication Sales by Type (2021-2026) & (K Units)
Table 43. North America Pig Disease Medication Sales Market Share by Type (2021-2026)
Table 44. North America Pig Disease Medication Sales by Application (2021-2026) & (K Units)
Table 45. North America Pig Disease Medication Sales Market Share by Application (2021-2026)
Table 46. Europe Pig Disease Medication Sales by Company (2021-2026) & (K Units)
Table 47. Europe Pig Disease Medication Sales Market Share by Company (2021-2026)
Table 48. Europe Pig Disease Medication Revenue by Company (2021-2026) & (US$ Million)
Table 49. Europe Pig Disease Medication Revenue Market Share by Company (2021-2026)
Table 50. Europe Pig Disease Medication Sales by Type (2021-2026) & (K Units)
Table 51. Europe Pig Disease Medication Sales Market Share by Type (2021-2026)
Table 52. Europe Pig Disease Medication Sales by Application (2021-2026) & (K Units)
Table 53. Europe Pig Disease Medication Sales Market Share by Application (2021-2026)
Table 54. China Pig Disease Medication Sales by Company (2021-2026) & (K Units)
Table 55. China Pig Disease Medication Sales Market Share by Company (2021-2026)
Table 56. China Pig Disease Medication Revenue by Company (2021-2026) & (US$ Million)
Table 57. China Pig Disease Medication Revenue Market Share by Company (2021-2026)
Table 58. China Pig Disease Medication Sales by Type (2021-2026) & (K Units)
Table 59. China Pig Disease Medication Sales Market Share by Type (2021-2026)
Table 60. China Pig Disease Medication Sales by Application (2021-2026) & (K Units)
Table 61. China Pig Disease Medication Sales Market Share by Application (2021-2026)
Table 62. Japan Pig Disease Medication Sales by Company (2021-2026) & (K Units)
Table 63. Japan Pig Disease Medication Sales Market Share by Company (2021-2026)
Table 64. Japan Pig Disease Medication Revenue by Company (2021-2026) & (US$ Million)
Table 65. Japan Pig Disease Medication Revenue Market Share by Company (2021-2026)
Table 66. Japan Pig Disease Medication Sales by Type (2021-2026) & (K Units)
Table 67. Japan Pig Disease Medication Sales Market Share by Type (2021-2026)
Table 68. Japan Pig Disease Medication Sales by Application (2021-2026) & (K Units)
Table 69. Japan Pig Disease Medication Sales Market Share by Application (2021-2026)
Table 70. MUGREEN Company Information
Table 71. MUGREEN Description and Business Overview
Table 72. MUGREEN Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 73. MUGREEN Pig Disease Medication Product
Table 74. MUGREEN Recent Development
Table 75. Tongren Pharmaceutical Company Information
Table 76. Tongren Pharmaceutical Description and Business Overview
Table 77. Tongren Pharmaceutical Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Tongren Pharmaceutical Pig Disease Medication Product
Table 79. Tongren Pharmaceutical Recent Development
Table 80. HUADI Group Company Information
Table 81. HUADI Group Description and Business Overview
Table 82. HUADI Group Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. HUADI Group Pig Disease Medication Product
Table 84. HUADI Group Recent Development
Table 85. Kunyuan Biology Company Information
Table 86. Kunyuan Biology Description and Business Overview
Table 87. Kunyuan Biology Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Kunyuan Biology Pig Disease Medication Product
Table 89. Kunyuan Biology Recent Development
Table 90. Hong Bao Company Information
Table 91. Hong Bao Description and Business Overview
Table 92. Hong Bao Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Hong Bao Pig Disease Medication Product
Table 94. Hong Bao Recent Development
Table 95. Xinheng Pharmaceutical Company Information
Table 96. Xinheng Pharmaceutical Description and Business Overview
Table 97. Xinheng Pharmaceutical Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Xinheng Pharmaceutical Pig Disease Medication Product
Table 99. Xinheng Pharmaceutical Recent Development
Table 100. Keda Animal Pharmaceutical Company Information
Table 101. Keda Animal Pharmaceutical Description and Business Overview
Table 102. Keda Animal Pharmaceutical Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Keda Animal Pharmaceutical Pig Disease Medication Product
Table 104. Keda Animal Pharmaceutical Recent Development
Table 105. Yuan Ye Biology Company Information
Table 106. Yuan Ye Biology Description and Business Overview
Table 107. Yuan Ye Biology Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Yuan Ye Biology Pig Disease Medication Product
Table 109. Yuan Ye Biology Recent Development
Table 110. Yi Ge Feng Company Information
Table 111. Yi Ge Feng Description and Business Overview
Table 112. Yi Ge Feng Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Yi Ge Feng Pig Disease Medication Product
Table 114. Yi Ge Feng Recent Development
Table 115. Jiuding Animal Pharmaceutical Company Information
Table 116. Jiuding Animal Pharmaceutical Description and Business Overview
Table 117. Jiuding Animal Pharmaceutical Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Jiuding Animal Pharmaceutical Pig Disease Medication Product
Table 119. Jiuding Animal Pharmaceutical Recent Development
Table 120. DEPOND Company Information
Table 121. DEPOND Description and Business Overview
Table 122. DEPOND Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. DEPOND Pig Disease Medication Product
Table 124. DEPOND Recent Development
Table 125. Bullvet Company Information
Table 126. Bullvet Description and Business Overview
Table 127. Bullvet Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Bullvet Pig Disease Medication Product
Table 129. Bullvet Recent Development
Table 130. Tong Yu Group Company Information
Table 131. Tong Yu Group Description and Business Overview
Table 132. Tong Yu Group Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Tong Yu Group Pig Disease Medication Product
Table 134. Tong Yu Group Recent Development
Table 135. Huabang Biotechnology Company Information
Table 136. Huabang Biotechnology Description and Business Overview
Table 137. Huabang Biotechnology Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Huabang Biotechnology Pig Disease Medication Product
Table 139. Huabang Biotechnology Recent Development
Table 140. Chengkang Pharmaceutical Company Information
Table 141. Chengkang Pharmaceutical Description and Business Overview
Table 142. Chengkang Pharmaceutical Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Chengkang Pharmaceutical Pig Disease Medication Product
Table 144. Chengkang Pharmaceutical Recent Development
Table 145. FANGTONG ANIMAL PHARMACEUTICAL Company Information
Table 146. FANGTONG ANIMAL PHARMACEUTICAL Description and Business Overview
Table 147. FANGTONG ANIMAL PHARMACEUTICAL Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. FANGTONG ANIMAL PHARMACEUTICAL Pig Disease Medication Product
Table 149. FANGTONG ANIMAL PHARMACEUTICAL Recent Development
Table 150. Jin He Biotechnology Company Information
Table 151. Jin He Biotechnology Description and Business Overview
Table 152. Jin He Biotechnology Pig Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Jin He Biotechnology Pig Disease Medication Product
Table 154. Jin He Biotechnology Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Pig Disease Medication Distributors List
Table 158. Pig Disease Medication Customers List
Table 159. Pig Disease Medication Market Trends
Table 160. Pig Disease Medication Market Drivers
Table 161. Pig Disease Medication Market Challenges
Table 162. Pig Disease Medication Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources


List of Figures
Figure 1. Pig Disease Medication Product Picture
Figure 2. Global Pig Disease Medication Sales (US$ Million) by Type (2021, 2025 & 2032)
Figure 3. Global Pig Disease Medication Sales Market Share by Type in 2025 & 2032
Figure 4. Diarrhea Product Picture
Figure 5. Virus Product Picture
Figure 6. Others Product Picture
Figure 7. Global Pig Disease Medication Sales (US$ Million) by Application (2021, 2025 & 2032)
Figure 8. Global Pig Disease Medication Sales Market Share by Application in 2025 & 2032
Figure 9. Farm Examples
Figure 10. Household Examples
Figure 11. Global Pig Disease Medication Sales, (US$ Million), 2021 VS 2025 VS 2032
Figure 12. Global Pig Disease Medication Sales Growth Rate (2021-2032) & (US$ Million)
Figure 13. Global Pig Disease Medication Sales (K Units) Growth Rate (2021-2032)
Figure 14. Global Pig Disease Medication Price Trends Growth Rate (2021-2032) & (US$/Unit)
Figure 15. Pig Disease Medication Report Years Considered
Figure 16. Global Market Pig Disease Medication Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Figure 17. Global Pig Disease Medication Revenue Market Share by Region: 2021 VS 2025
Figure 18. North America Pig Disease Medication Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. North America Pig Disease Medication Sales (K Units) Growth Rate (2021-2032)
Figure 20. Europe Pig Disease Medication Revenue (US$ Million) Growth Rate (2021-2032)
Figure 21. Europe Pig Disease Medication Sales (K Units) Growth Rate (2021-2032)
Figure 22. China Pig Disease Medication Revenue (US$ Million) Growth Rate (2021-2032)
Figure 23. China Pig Disease Medication Sales (K Units) Growth Rate (2021-2032)
Figure 24. Japan Pig Disease Medication Revenue (US$ Million) Growth Rate (2021-2032)
Figure 25. Japan Pig Disease Medication Sales (K Units) Growth Rate (2021-2032)
Figure 26. Global Pig Disease Medication Revenue Share by Type (2021-2026)
Figure 27. Global Pig Disease Medication Sales Share by Type (2027-2032)
Figure 28. Global Pig Disease Medication Revenue Share by Type (2027-2032)
Figure 29. Global Pig Disease Medication Revenue Share by Application (2021-2026)
Figure 30. Global Pig Disease Medication Revenue Market Share by Application in 2021 & 2025
Figure 31. Global Pig Disease Medication Sales Share by Application (2027-2032)
Figure 32. Global Pig Disease Medication Revenue Share by Application (2027-2032)
Figure 33. Global Pig Disease Medication Sales Share by Company (2025)
Figure 34. Global Pig Disease Medication Revenue Share by Company (2025)
Figure 35. Global 5 Largest Pig Disease Medication Players Market Share by Revenue in Pig Disease Medication: 2021 & 2025
Figure 36. Pig Disease Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 37. Manufacturing Cost Structure of Pig Disease Medication
Figure 38. Manufacturing Process Analysis of Pig Disease Medication
Figure 39. Pig Disease Medication Industrial Chain
Figure 40. Channels of Distribution (Direct Vs Distribution)
Figure 41. Distributors Profiles
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed